Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Gubra: Åbner kontor på østkysten - Boston

By Claus ThestrupCEO, Sweden
Gubra

Gubra: Åbner kontor på østkysten - Boston

Selskabet annoncerer hertil morgen, at man etablerer sig på den amerikanske østkyst. I første halvår kom mere en 50% af omsætningen i CRO forretningen fra USA. For at være tættere på kunderne samt at kunne vokse forretningen yderligere vælger selskabet nu fysisk etablering.

Begge forretningsben CRO og D&P vil være repræsenteret.

Læs hele meddelelsen her: Gubra USA

Disclaimer: HC Andersen Capital modtager betaling fra Gubra for en Digital IR/Corporate Visibility abonnementsaftale. /Claus Thestrup  kl. 8:35 AM d. 24/10-2023.

Login required

This content is only available for logged in users

Create account

Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They primarily conduct research and development in the area of metabolic and fibrotic diseases. The company's product portfolio includes several brands and drugs, and the operations are conducted on a global level, with the largest presence in North America and the Nordic region. The headquarters are located in Hørsholm, Denmark.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.